Metser U - Search Results

1

CXCR4-Targeted PET Imaging in Hematologic Malignancies: A Systematic Review and Meta-analysis.

Chavoshi M, Mirshahvalad SA, Kohan A, Ortega C, Metser U, Farag A, Kridel R, Hodgson D, Bhella S, Kukreti V, Veit-Haibach P. Chavoshi M, et al. Among authors: metser u. Clin Nucl Med. 2024 Sep 11. doi: 10.1097/RLU.0000000000005426. Online ahead of print. Clin Nucl Med. 2024. PMID: 39259697

2

(18)F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer.

Metser U, Rashidi F, Moshonov H, Wong R, Knox J, Guindi M, Darling G. Metser U, et al. Ann Nucl Med. 2014 May;28(4):295-303. doi: 10.1007/s12149-014-0812-2. Epub 2014 Jan 29. Ann Nucl Med. 2014. PMID: 24474598

3

18F-FDG-PET/CT in the Staging and Management of Melanoma: A Prospective Multicenter Ontario PET Registry Study.

Singnurkar A, Wang J, Joshua AM, Langer DL, Metser U. Singnurkar A, et al. Among authors: metser u. Clin Nucl Med. 2016 Mar;41(3):189-93. doi: 10.1097/RLU.0000000000000996. Clin Nucl Med. 2016. PMID: 26447374

4

FDG PET/CT Response Assessment Criteria for Patients with Hodgkin's and Non-Hodgkin's Lymphoma at End of Therapy: A Multiparametric Approach.

Metser U, Mohan R, Beckley V, Moshonov H, Hodgson D, Murphy G. Metser U, et al. Nucl Med Mol Imaging. 2016 Mar;50(1):46-53. doi: 10.1007/s13139-015-0368-7. Epub 2015 Sep 29. Nucl Med Mol Imaging. 2016. PMID: 26941859 Free PMC article.

5

Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.

Metser U, Halankar J, Langer D, Mohan R, Hussey D, Hadas M, Tamir S. Metser U, et al. Ann Nucl Med. 2017 Feb;31(2):153-162. doi: 10.1007/s12149-016-1139-y. Epub 2016 Nov 15. Ann Nucl Med. 2017. PMID: 27848159

6

[¹⁸ F]-FDG PET/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry study.

Metser U, Dudebout J, Baetz T, Hodgson DC, Langer DL, MacCrostie P, Mak V, Tau N. Metser U, et al. Cancer. 2017 Aug 1;123(15):2860-2866. doi: 10.1002/cncr.30672. Epub 2017 Mar 13. Cancer. 2017. PMID: 28295218 Free article.

7

Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review.

Singnurkar A, Poon R, Metser U. Singnurkar A, et al. Among authors: metser u. Ann Nucl Med. 2017 Jun;31(5):366-378. doi: 10.1007/s12149-017-1164-5. Epub 2017 Mar 28. Ann Nucl Med. 2017. PMID: 28353197 Review.

8

Benign Cutaneous and Subcutaneous Lesions on FDG-PET/CT.

Metser U, Tau N. Metser U, et al. Semin Nucl Med. 2017 Jul;47(4):352-361. doi: 10.1053/j.semnuclmed.2017.02.007. Epub 2017 Apr 11. Semin Nucl Med. 2017. PMID: 28583275 Review.

9

¹⁸F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center.

Elliott HS, Metser U, de Perrot M, Cho J, Bradbury P, Veit-Haibach P, Hussey D, Noam T. Elliott HS, et al. Among authors: metser u. Br J Radiol. 2018 Jun;91(1086):20170814. doi: 10.1259/bjr.20170814. Epub 2018 Mar 29. Br J Radiol. 2018. PMID: 29498536 Free PMC article.

10

¹⁸F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.

Parvez A, Tau N, Hussey D, Maganti M, Metser U. Parvez A, et al. Among authors: metser u. Ann Nucl Med. 2018 Jul;32(6):410-416. doi: 10.1007/s12149-018-1260-1. Epub 2018 May 12. Ann Nucl Med. 2018. PMID: 29754276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters